首頁 > 市場調查報告書 > 醫療設備

e保健醫院 IT

市場調查報告書

商品編碼

1419129

數位藥局市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按藥物類型、產品、平台和地理位置

Digital Pharmacy Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Type, Product, Platform, and Geography

出版日期: 2023年11月17日 | 出版商:

The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格

簡介目錄

數位藥局市場預計將從2022年的964.28億美元成長到2030年的3,638.78億美元；預計2022年至2030年CAGR為18.1%。

COVID-19 大流行期間線上購買處方藥的激增以及人們越來越傾向於線上平台是推動數位藥房市場成長的幾個因素。

數位藥房是一家獲得許可的藥房，涵蓋透過個人風格將高科技和高效解決方案相結合的實體，有助於將新的、現有的和數位療法商業化。此解決方案簡化了配藥流程，增強了利害關係人的體驗，並為生物製藥製造商提供了可行的見解來闡明處方流程。例如，數位藥局可以幫助生物製藥公司消除障礙，使配藥藥局能夠獲得乾淨且可立即配藥的處方。

市場趨勢

創新電子藥局模式

根據 SHOPS Plus 2019 年 12 月發布的報告，透過私營部門 (SHOPS) Plus 維持健康成果

印度的專案團隊宣布與中央邦政府和製藥公司 Medlife International 合作，推出創新的藥物到家電子藥房模式來對抗結核病 (TB)。 SHOPS Plus Prohect 團隊設計了服務交付模式，透過電子藥局模式/平台加強結核病服務。例如，在印度，結核病疫情正在下降。然而，該國仍擁有最多的結核病患者，每年有 50 萬例未確診。因此，SHOP Plus正致力於利用科技，透過電子藥局模式，為患者提供上門診斷和治療支援服務。 SHOP Plus 的此類措施將有助於增加患者獲得結核病服務的機會。透過SHOP Plus專案設計的電子藥局平台，結核病患者可以為結核病患者開立居家痰液檢測材料，並且檢測是遠端完成的。電子藥房代理將提取材料並將其運送到實驗室設施。痰液材料處理完畢後，實驗室會將病患的檢測報告上傳至電子藥局平台。結核病患者可以查看報告，醫生可以為患者開立治療處方。該電子藥房平台還採用通訊技術來追蹤患者的治療依從性和未來的訂單。這種創新的電子藥局模式將為 2020-2030 年預測期內的成長提供利潤豐厚的市場機會。

市場趨勢

基於網路的整合線上藥局介面成為主要趨勢

整合電子醫療保健系統與藥劑師和患者可以存取的基於網路的藥房介面相結合，可能會成為未來幾年數位藥房市場的新趨勢。線上藥局為購買藥品的人提供線上支援的程式就是此類介面的一個顯著例子。例如，服用他汀類藥物作為治療的一部分的患者可能會停止服藥或出現服藥不規則的情況。與接受過培訓的藥房團隊成員進行提醒和即時聊天，為服用他汀類處方藥的人提供依從性支持，可以幫助避免停藥。

基於平台的見解

從平台來看，數位藥局市場分為應用程式平台和網站平台。基於應用程式的應用程式進一步細分為遠距醫療藥房應用程式、藥物管理應用程式、健康和保健應用程式、複合藥房應用程式等。基於應用程式的細分市場將在 2022 年佔據更大的市場佔有率，預計該細分市場在預測期內的複合CAGR將達到 17.60%。預計 2022 年至 2030 年期間，遠距醫療藥房應用程式將佔據基於應用程式細分市場的最大佔有率。可以從任何地方透過遠距醫療應用程式存取虛擬醫療保健。根據 CDC 2021 年發布的資料，2020 年有 37.0% 的成年人使用遠距醫療，包括醫療服務提供者就診、線上處方和心理健康服務。最好的遠距醫療應用程式可以免費下載並且易於使用，而且它們通常完全涵蓋保險服務。遠距醫療藥局應用程式的一些範例包括 Hims & Hers、GoodRx、K Health 和 Doctor on Demand。 GoodRx 提供低成本就診、透過電子郵件輕鬆補充處方以及無需健康保險的就診等服務。

根據藥品類型，數位藥局市場分為處方藥和非處方藥。處方藥細分市場將在 2022 年佔據更大的市場佔有率，預計該細分市場在預測期內的複合CAGR將達到 17.83%。根據產品，數位藥局市場分為個人護理、維生素和補充劑、藥品和治療以及其他產品。藥物和治療領域進一步分為性健康、神經系統疾病、心臟照護、糖尿病、減重等。藥物和治療領域在 2022 年佔據更大的市場佔有率，預計該領域在預測期內的CAGR將達到 17.87%。從平台來看，數位藥局市場分為應用程式平台和網站平台。基於應用程式的應用程式進一步細分為遠距醫療藥房應用程式、藥物管理應用程式、健康和保健應用程式、複合藥房應用程式等。基於應用程式的細分市場將在 2022 年佔據更大的市場佔有率，預計該細分市場在預測期內的複合CAGR將達到 17.60%。按性別分類，市場分為男性和女性。到 2022 年，女性細分市場將佔據更大的市場佔有率，預計該細分市場在預測期內的複合CAGR將達到 17.64%。

歐洲
- 德國
- 法國
- 義大利
- 西班牙
- 英國
- 歐洲其他地區
亞太
- 澳洲
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區
南美洲和中美洲
- 巴西
- 阿根廷
- 南美洲和中美洲其他地區

第 11 章：Covid-19 前後的影響

第 12 章：產業格局

併購
協議、合作、合資企業
新產品發布
擴張和其他策略發展

第13章：競爭格局

關鍵參與者的熱圖分析
公司定位與專注

第 14 章：數位藥局市場 - 主要公司概況

Alto

注意 - 將為以下公司列表提供類似資訊

藥包
膠囊
CVS健康
信諾
沃爾格林公司
沃爾瑪公司
亞馬遜公司
克羅格公司
好接收器

第 15 章：附錄

詞彙表
關於 Insight Partners
市場情報雲

簡介目錄

Product Code: TIPRE00031438

The digital pharmacy market is expected to grow from US$ 96.428 billion in 2022 to US$ 363.878 billion by 2030; it is expected to grow at a CAGR of 18.1% from 2022 to 2030.

Upsurge in online purchase of prescription medicines during the COVID-19 pandemic and an increasing inclination toward online platforms are a few factors driving the digital pharmacy market growth.

A digital pharmacy is a licensed pharmacy covering an entity combining high-tech and efficient solutions through a personal touch that helps commercialize new, existing, and digital therapies. The solution simplifies the process of filling a prescription, enhances stakeholders' experiences, and clarifies the prescription journey with actionable insights for biopharma manufacturers. For example, digital pharmacies can help biopharma companies remove barriers, enabling dispensing pharmacies to receive clean and ready-to-dispense prescriptions.

Market Trend

Innovative E-Pharmacy Model

According to the published report by SHOPS Plus in December 2019, Sustaining Health Outcomes through the Private Sector (SHOPS) Plus

The project team in India announced a partnership with the State Government of Madhya Pradesh and the pharmaceutical company Medlife International to launch an innovative, drug-to-doorstep e-pharmacy model to fight against tuberculosis (TB). The SHOPS Plus Prohect team designed the service delivery model to strengthen the TB services through an e-pharmacy model/platform. For example, in India, the TB epidemic is declining. However, the country still holds the most significant number of TB patients, with half a million cases carried undiagnosed annually. Therefore, SHOP Plus is working to utilize technology to provide diagnosis and treatment support services available at the patient's doorstep through an e-pharmacy model. Such initiatives by SHOP Plus will help to increase access to TB services among patients. With the e-pharmacy platform designed by the SHOP Plus project, TB patients can prescribe home sputum testing materials for TB patients, and the test is completed remotely. The e-pharmacy agent will pick up the material and deliver it to the lab facility. After processing the sputum material, the lab will upload the patient's testing report on the e-pharmacy platform. TB patients can view the report, and physicians can prescribe the treatment for the patient. The e-pharmacy platform also features communication technology to follow up with patients' treatment adherence and future orders. Such innovative e-pharmacy models will provide lucrative market opportunities for growth in the forecast period 2020-2030.

Market Trend

Integrated Web-Based Online Pharmacy Interface Emerges as Key Trend

Integrated e-healthcare systems incorporated with web-based pharmacy interfaces that are accessible to pharmacists and patients are likely to emerge as new trends in the digital pharmacy market in the coming years. Programs made available by online pharmacies to provide online support to people buying medicines are a notable example of such interfaces. For instance, patients administered with statins as a part of their treatments are likely to discontinue or show irregularities in taking medicines. Reminders and live chat with a pharmacy team member trained in providing adherence support to people consuming statin-based prescribed medicines can help avoid the discontinuation of doses.

Platform-Based Insights

In terms of platform, the digital pharmacy market is categorized into app-based and website-based. The app-based is further segmented into telehealth pharmacy apps, medication management apps, health and wellness apps, compounding pharmacy apps, and others. The app-based segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.60% during the forecast period. Telehealth pharmacy apps are expected to account for a maximum share of the market for the app-based segment during 2022-2030. Virtual healthcare can be accessed through telehealth apps from anywhere. According to CDC data published in 2021, 37.0% of adults used telemedicine in 2020, including provider visits, online prescriptions, and mental health services. The best telehealth apps can be downloaded free of cost and are easy to use, and they often completely cover insurance services. A few examples of telehealth pharmacy apps are Hims & Hers, GoodRx, K Health, and Doctor on Demand. GoodRx offers services such as low-cost visits, easy prescription refills via mail, and visits without health insurance.

Based on drug type, the digital pharmacy market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.83% during the forecast period. Based on product, the digital pharmacy market is segmented into personal care, vitamins & supplements, medicines & treatments, and other products. The medicine & treatments segment is further segregated as sexual health, neurological disorders, heart care, diabetes, weight loss, and others. The medicine and treatment segment held a larger market share in 2022, and the segment is anticipated to register a higher CAGR of 17.87% during the forecast period. In terms of platform, the digital pharmacy market is categorized into app-based and website-based. The app-based is further segmented into telehealth pharmacy apps, medication management apps, health and wellness apps, compounding pharmacy apps, and others. The app-based segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.60% during the forecast period. By gender, the market is bifurcated into males and females. The females segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.64% during the forecast period.

1. Introduction

1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness Analysis

3. Research Methodology

4. Digital Pharmacy Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Digital Pharmacy Market - Key Market Dynamics

5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints

6. Digital Pharmacy Market - Global Market Analysis

6.1 Digital Pharmacy - Global Market Overview
6.2 Digital Pharmacy - Global Market and Forecast to 2030

7. Digital Pharmacy Market - Revenue Analysis (USD Million) - By Drug Type, 2020-2030

7.1 Overview
7.2 Prescription Medicines
7.3 Over the Counter Products

8. Digital Pharmacy Market - Revenue Analysis (USD Million) - By Products, 2020-2030

8.1 Overview
8.2 Medicine
8.3 Personal Care
8.4 Vitamins and Supplements
8.5 Others

9. Digital Pharmacy Market - Revenue Analysis (USD Million) - By Platform, 2020-2030

9.1 Overview
9.2 Apps
9.3 Websites

10. Digital Pharmacy Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

10.1 North America
- 10.1.1 North America Digital Pharmacy Market Overview
- 10.1.2 North America Digital Pharmacy Market Revenue and Forecasts to 2030
- 10.1.3 North America Digital Pharmacy Market Revenue and Forecasts and Analysis - By Drug Type
- 10.1.4 North America Digital Pharmacy Market Revenue and Forecasts and Analysis - By Products
- 10.1.5 North America Digital Pharmacy Market Revenue and Forecasts and Analysis - By Platform
- 10.1.6 North America Digital Pharmacy Market Revenue and Forecasts and Analysis - By Countries
  - 10.1.6.1 United States Digital Pharmacy Market
    - 10.1.6.1.1 United States Digital Pharmacy Market, by Drug Type
    - 10.1.6.1.2 United States Digital Pharmacy Market, by Products
    - 10.1.6.1.3 United States Digital Pharmacy Market, by Platform
  - 10.1.6.2 Canada Digital Pharmacy Market
    - 10.1.6.2.1 Canada Digital Pharmacy Market, by Drug Type
    - 10.1.6.2.2 Canada Digital Pharmacy Market, by Products
    - 10.1.6.2.3 Canada Digital Pharmacy Market, by Platform
  - 10.1.6.3 Mexico Digital Pharmacy Market
    - 10.1.6.3.1 Mexico Digital Pharmacy Market, by Drug Type
    - 10.1.6.3.2 Mexico Digital Pharmacy Market, by Products
    - 10.1.6.3.3 Mexico Digital Pharmacy Market, by Platform

Note - Similar analysis would be provided for below mentioned regions/countries

10.2 Europe
- 10.2.1 Germany
- 10.2.2 France
- 10.2.3 Italy
- 10.2.4 Spain
- 10.2.5 United Kingdom
- 10.2.6 Rest of Europe
10.3 Asia-Pacific
- 10.3.1 Australia
- 10.3.2 China
- 10.3.3 India
- 10.3.4 Japan
- 10.3.5 South Korea
- 10.3.6 Rest of Asia-Pacific
10.4 Middle East and Africa
- 10.4.1 South Africa
- 10.4.2 Saudi Arabia
- 10.4.3 U.A.E
- 10.4.4 Rest of Middle East and Africa
10.5 South and Central America
- 10.5.1 Brazil
- 10.5.2 Argentina
- 10.5.3 Rest of South and Central America

11. Pre and Post Covid-19 Impact

12. Industry Landscape

12.1 Mergers and Acquisitions
12.2 Agreements, Collaborations, Joint Ventures
12.3 New Product Launches
12.4 Expansions and Other Strategic Developments

13. Competitive Landscape

13.1 Heat Map Analysis by Key Players
13.2 Company Positioning and Concentration

14. Digital Pharmacy Market - Key Company Profiles

14.1 Alto
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments

Note - Similar information would be provided for below list of companies